Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You are trying to make others here aware of something but you are unexperienced to the process of building and growing a business.
Again you made the same mistake you are accusing EVIO of. Which is over paying. You wouldn’t be so mad had you waited for the $0.60s/$0.70s and added there. But you paid ~$35million for your shares. So own that.
Oh you’re new to investing and trading and made a mistake in timing?! EVIO is new to testing cannabis and growing a business too.
There are many positives here in due time. I like what I see. We are capturing market share and building brand recognition before states even mandate testing. Con is it costs money with not a lot of revenues but if you wait too long you miss out on market share and first opportunity at customers and customer retention. No decision is perfect or doesn’t have risk of downside.
There was a guy posting here almost 2 years ago saying EVIO was too late into Cali which would have resulted in 2 years of little revenues and a loss.
This is moving and will move slower than I anticipated and thought but that’s business and life. They are putting pieces together for where they can with where the market is at.
We bought labs knowing they wouldn’t produce revenue to capture market share and brand recognition with future revenue. That has value. Repeat after me this is a start up company and play for the future. We are setting up for future revenue and branding for future valuation. This must be beyond your business sense. Businesses run at losses for multiple years to grow brand recognition and capture market share. Many steps before producing revenue (especially in markets that are less than months old!)
I see you made the same mistake you are accusing them of. Over paying for labs. You paid over $18 million for the labs yourself! You said $1.76? That’s almost $35million you paid!
Then add networking, marketing, customer retention, hiring, training, brand recognition.. the list goes on and on.
Evio getting those things in line.
If it was that easy everyone would do it!
There wouldn’t be empty units for lease anywhere or businesses closing ever.
Why did you pay over $18mill for shares? If you think $1mill a lab is over priced then that means you should be waiting for a market cap of $10mill to buy (~$0.50). Timing is everything. The market seems to think a lab is worth over $1mill based on market cap. Premiums are put on growth opportunity. Businesses sell for assets, goodwill, proprietary, turn key, and projections (depending on the market).
EVIO was too early in many purchases but NO ONE thought it would take this long to implement testing into legal markets. These laws passed 2 years ago. 2 short years ago. It takes many years to build a successful business. We haven’t even had one month or full revenues (still awaiting 2 labs in Cali we paid for and Mass). Usually takes two successful years to get loans.
Employees can talk all they want but can’t even run their own lives cash flow positive and wouldn’t make the sacrifice or risks involved to make that jump. They don’t understand underlying expenses, margins, or valuations. Easier said than done.
What’s your guess for Q4 revs?
Was really hoping we’d get a PR before Oct 1st about both Cali build puts being ready for business. Appears there’s still time before Mass rec gets up and running.
EVIO attending CWCBexpo in Boston Oct 17-20. I may look to attend. There are seminars and workshops about the industry. They are at this same expo in LA currently (Sept 26-29).
Why do my AON orders not show up on a bid? Not here btw.
Thanks.
Thanks appreciate it.
Market cap should be how many X revenue?
When’s next report due? November 15?
Thanks
Good point.
I need to do some comparison in square footage of buildings at minimum. It would be nice to know how much build out cost/ what they have in assets for better comparison.
With that potential comparison I see .005 before proven revenues with PRs and 8ks.
I was looking at that chart today as well. I went with the higher risk higher return play which is here.
I was simple comparing its potential and what I’m holding and hoping for if they execute.
If PZOO can capture same revenue.
That’s my bet but about $0.02 is what I’m holding for. DIGP once traded at $0.50 at peak.
I don’t see higher than $0.02.
Agree
Lmao
We need over 600k in volume for several days to push us up.
91k in 10min?
Huge wall at .85
Even if he does lower it to what he said he would, that amount is still a hefty load of potential dilution. And I don’t care what you think. I’m not giving my opinion or entertaining your opinion on if he will or he won’t. I’m stating a fact that even lowering the A/S still leaves a huge amount of dilution capable.
Lower A/S to the 100million they targeted for is still ample shares to dilute significantly.
How bout CSTI? I think I saw they had a 20000 ask.
Honestly hoping for low $0.70s. I added a small amount Friday. I’m anticipating PRs before months end about completed lease build outs in Cali ready for Q1. We’ve already paid for these.
Sounds good. I’d have to say I see atleast $5 by 2020. Our market cap is $8million right now. We have that in assets. I’m adding here as well.
Really hoping to get opening of Cali lab PRs by end of this month. Q1 starts in 23 days.
Could be by February financials.
We are at an $8million market cap at $0.78. If we do $3 million in revenue we should be at a minimum of $15million and up to $45million. That’s about $1.46 on low end with current share structure and $4.38 on high end. Not sure on how many more shares need to be diluted but this is based off our current situation with current labs. As more dilution comes revenues should catch up with 2 more Cali labs and a Mass labs. Would still assume math would fall into this range (2x diluted shares:2x revenues) Why is 5x-15x earnings unreasonable? Especially with so many assets?
Lol the board is funny today. Must be all that wacky tobaccy.
Lol
Revenues aren’t dropping. Have you read the financials? More like stagnant. We are still up YOY.